Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Metabolic Syndrome X and CYP2C19[original query] |
---|
Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients. Biomarkers in medicine 2011 Aug 5 (4): 439-49. Ruaño Gualberto, Villagra David, Szarek Bonnie, Windemuth Andreas, Kocherla Mohan, Gorowski Krystyna, Berrezueta Christopher, Schwartz Harold I, Goethe Jo |
Genetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal. Diabetology & metabolic syndrome 2014 6 (1): 23. Gaio Vânia, Nunes Baltazar, Fernandes Aida, Mendonça Francisco, Horta Correia Filomena, Beleza Alvaro, Gil Ana Paula, Bourbon Mafalda, Vicente Astrid, Dias Carlos Matias, Barreto da Silva Mar |
Genetic Determinants of Clozapine-Induced Metabolic Side Effects. Canadian journal of psychiatry. Revue canadienne de psychiatrie 2016 Sep . Vasudev Kamini, Choi Yun-Hee, Norman Ross, Kim Richard B, Schwarz Ute |
CYP2C19*17 protects against metabolic complications of clozapine treatment. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2017 Jun 1-17. Piatkov Irina, Caetano Dorgival, Assur Yolinda, Lau Sue Lynn, Coelho Micheline, Jones Trudi, Nguyen Tristan, Boyages Steven, McLean Ma |
Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy. Cardiology 2018 Jan 139 (2): 132-136. Golukhova Elena Z, Grigoryan Marina V, Ryabinina Mariya N, Bulaeva Naida I, Serebruany Victor |
- Page last reviewed:Feb 1, 2024
- Content source: